Resureccion, Jada Mechaela .

HRN: 25-56-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/28/2024
08/04/2024
PO
5ml
TID
Amoebiasis
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: